NCT02096666 2021-12-28A Phase 1/2 Study Evaluating AMG 337 in Asian SubjectsAmgenPhase 1/2 Completed11 enrolled
NCT02016534 2017-07-02Phase 2 Study of AMG 337 in MET Amplified Gastric/Esophageal Adenocarcinoma or Other Solid TumorsAmgenPhase 2 Terminated60 enrolled